Janus Henderson Group
TSVT

Janus Henderson Group’s 2seventy bio TSVT Stock Holding History

Janus Henderson Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,178
Closed -$91K – 2611
2023
Q3 		$91K Sell
23,178
-6
-0% -$39 ﹤0.01% 2527
2023
Q2 		$235K Buy
23,184
+9,830
+74% +$104K ﹤0.01% 2372
2023
Q1 		$136K Buy
+13,354
New +$153K ﹤0.01% 2576

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Janus Henderson Group's TSVT Position: Q4 2023 in Review

Janus Henderson Group sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 23,178 shares — an estimated $91K sold.

Janus Henderson Group first reported a position in TSVT in Q1 2023 and held it in 3 quarters. The position peaked at $235K in Q2 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Janus Henderson Group reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 23,178 2seventy bio shares in Q4 2023, an estimated $91K.
  • Janus Henderson Group first reported a position in 2seventy bio in Q1 2023 and held it in 3 quarters.
  • Janus Henderson Group's 2seventy bio position peaked at $235K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.